These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
456 related articles for article (PubMed ID: 10766191)
1. Loss of expression of Dpc4 in pancreatic intraepithelial neoplasia: evidence that DPC4 inactivation occurs late in neoplastic progression. Wilentz RE; Iacobuzio-Donahue CA; Argani P; McCarthy DM; Parsons JL; Yeo CJ; Kern SE; Hruban RH Cancer Res; 2000 Apr; 60(7):2002-6. PubMed ID: 10766191 [TBL] [Abstract][Full Text] [Related]
2. Pancreatic intraepithelial neoplasia and infiltrating adenocarcinoma: analysis of progression and recurrence by DPC4 immunohistochemical labeling. McCarthy DM; Brat DJ; Wilentz RE; Yeo CJ; Cameron JL; Kern SE; Hruban RH Hum Pathol; 2001 Jun; 32(6):638-42. PubMed ID: 11431719 [TBL] [Abstract][Full Text] [Related]
3. Overexpression of p21(WAF1/CIP1) is an early event in the development of pancreatic intraepithelial neoplasia. Biankin AV; Kench JG; Morey AL; Lee CS; Biankin SA; Head DR; Hugh TB; Henshall SM; Sutherland RL Cancer Res; 2001 Dec; 61(24):8830-7. PubMed ID: 11751405 [TBL] [Abstract][Full Text] [Related]
4. Direct correlation between proliferative activity and dysplasia in pancreatic intraepithelial neoplasia (PanIN): additional evidence for a recently proposed model of progression. Klein WM; Hruban RH; Klein-Szanto AJ; Wilentz RE Mod Pathol; 2002 Apr; 15(4):441-7. PubMed ID: 11950919 [TBL] [Abstract][Full Text] [Related]
5. Inactivation of the p16 (INK4A) tumor-suppressor gene in pancreatic duct lesions: loss of intranuclear expression. Wilentz RE; Geradts J; Maynard R; Offerhaus GJ; Kang M; Goggins M; Yeo CJ; Kern SE; Hruban RH Cancer Res; 1998 Oct; 58(20):4740-4. PubMed ID: 9788631 [TBL] [Abstract][Full Text] [Related]
6. Allelic loss is often the first hit in the biallelic inactivation of the p53 and DPC4 genes during pancreatic carcinogenesis. Lüttges J; Galehdari H; Bröcker V; Schwarte-Waldhoff I; Henne-Bruns D; Klöppel G; Schmiegel W; Hahn SA Am J Pathol; 2001 May; 158(5):1677-83. PubMed ID: 11337365 [TBL] [Abstract][Full Text] [Related]
7. Clinicopathological features of pancreatic intraepithelial neoplasias and their relationship to intraductal papillary-mucinous tumors. Takaori K; Kobashi Y; Matsusue S; Matsui K; Yamamoto T J Hepatobiliary Pancreat Surg; 2003; 10(2):125-36. PubMed ID: 14505145 [TBL] [Abstract][Full Text] [Related]
8. Multicomponent analysis of the pancreatic adenocarcinoma progression model using a pancreatic intraepithelial neoplasia tissue microarray. Maitra A; Adsay NV; Argani P; Iacobuzio-Donahue C; De Marzo A; Cameron JL; Yeo CJ; Hruban RH Mod Pathol; 2003 Sep; 16(9):902-12. PubMed ID: 13679454 [TBL] [Abstract][Full Text] [Related]
10. [Alterations of DPC4/SMAD4/MADH4 gene detected in paraffin-embedded tissues of human pancreatic carcinomas]. Gu LJ; Chen J; Liu TH; Cui QC; Lu ZH; Li L; Gao J Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2002 Apr; 24(2):165-9. PubMed ID: 12905795 [TBL] [Abstract][Full Text] [Related]
11. Immunohistochemical labeling for the Dpc4 gene product is a specific marker for adenocarcinoma in biopsy specimens of the pancreas and bile duct. Tascilar M; Offerhaus GJ; Altink R; Argani P; Sohn TA; Yeo CJ; Cameron JL; Goggins M; Hruban RH; Wilentz RE Am J Clin Pathol; 2001 Dec; 116(6):831-7. PubMed ID: 11764071 [TBL] [Abstract][Full Text] [Related]
12. The relationship between loss expression of DPC4/Smad4 gene and carcinogenesis of pancreatobiliary carcinoma. Tang ZH; Zou SQ; Hao YH; Wang BJ; Yang XP; Chen QQ; Qiu FZ Hepatobiliary Pancreat Dis Int; 2002 Nov; 1(4):624-9. PubMed ID: 14607700 [TBL] [Abstract][Full Text] [Related]
13. Neoplasms of the ampulla of vater with concurrent pancreatic intraductal neoplasia: a histological and molecular study. Agoff SN; Crispin DA; Bronner MP; Dail DH; Hawes SE; Haggitt RC Mod Pathol; 2001 Mar; 14(3):139-46. PubMed ID: 11266517 [TBL] [Abstract][Full Text] [Related]
14. [Expression of DPC4/Smad4, p21wafI, and p16 in human pancreatic cancer]. Gu LJ; Chen J; Lu ZH; Li L; Zhou WX; Luo YF Ai Zheng; 2002 Feb; 21(2):132-7. PubMed ID: 12479060 [TBL] [Abstract][Full Text] [Related]
15. Ductal neoplasia of the pancreas: nosologic, clinicopathologic, and biologic aspects. Adsay NV; Basturk O; Cheng JD; Andea AA Semin Radiat Oncol; 2005 Oct; 15(4):254-64. PubMed ID: 16183479 [TBL] [Abstract][Full Text] [Related]
16. Differing rates of loss of DPC4 expression and of p53 overexpression among carcinomas of the proximal and distal bile ducts. Argani P; Shaukat A; Kaushal M; Wilentz RE; Su GH; Sohn TA; Yeo CJ; Cameron JL; Kern SE; Hruban RH Cancer; 2001 Apr; 91(7):1332-41. PubMed ID: 11283934 [TBL] [Abstract][Full Text] [Related]
17. Pancreatic intraepithelial neoplasia in heterotopic pancreas: evidence for the progression model of pancreatic ductal adenocarcinoma. Zhang L; Sanderson SO; Lloyd RV; Smyrk TC Am J Surg Pathol; 2007 Aug; 31(8):1191-5. PubMed ID: 17667542 [TBL] [Abstract][Full Text] [Related]
18. [Pathologic characteristics and evaluation of the pancreatic cancer]. Fukushima N; Mukai K Gan To Kagaku Ryoho; 2005 May; 32(5):599-604. PubMed ID: 15918557 [TBL] [Abstract][Full Text] [Related]
19. [Precursors to pancreatic cancer]. Søreide K; Immervoll H; Molven A Tidsskr Nor Laegeforen; 2006 Mar; 126(7):905-8. PubMed ID: 16554881 [TBL] [Abstract][Full Text] [Related]
20. Dpc-4 protein is expressed in virtually all human intraductal papillary mucinous neoplasms of the pancreas: comparison with conventional ductal adenocarcinomas. Iacobuzio-Donahue CA; Klimstra DS; Adsay NV; Wilentz RE; Argani P; Sohn TA; Yeo CJ; Cameron JL; Kern SE; Hruban RH Am J Pathol; 2000 Sep; 157(3):755-61. PubMed ID: 10980115 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]